Your browser doesn't support javascript.
loading
Dual Bioorthogonal Labeling of the Amyloid-ß Protein Precursor Facilitates Simultaneous Visualization of the Protein and Its Cleavage Products.
van Husen, Lea S; Schedin-Weiss, Sophia; Trung, Minh Nguyen; Kazmi, Manija A; Winblad, Bengt; Sakmar, Thomas P; Elsässer, Simon J; Tjernberg, Lars O.
Afiliación
  • van Husen LS; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Solna, Sweden.
  • Schedin-Weiss S; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Solna, Sweden.
  • Trung MN; Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.
  • Kazmi MA; Institute of Chemistry, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Winblad B; Laboratory of Chemical Biology & Signal Transduction, The Rockefeller University, New York, NY, USA.
  • Sakmar TP; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Solna, Sweden.
  • Elsässer SJ; Karolinska University Hospital, Theme Aging, Stockholm, Sweden.
  • Tjernberg LO; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Solna, Sweden.
J Alzheimers Dis ; 72(2): 537-548, 2019.
Article en En | MEDLINE | ID: mdl-31609694
The amyloid-ß protein precursor (AßPP) is critical in the pathophysiology of Alzheimer's disease (AD), since two-step proteolytic processing of AßPP generates the neurotoxic amyloid-ß peptide (Aß). We developed a dual fluorescence labeling system to study the exact subcellular location of γ-secretase cleavage of AßPP. The C-terminal tail of AßPP was fluorescently labeled using a SNAP-tag, while the Aß region of AßPP was fluorescently tagged with a dye at a genetically-encoded noncanonical amino acid (ncAA). The ncAA was introduced at specific positions in AßPP using a genetic code expansion strategy and afterwards, the reactive side-chain of the ncAA was coupled to the dye using a bioorthogonal labeling chemistry. In proof-of-concept experiments, HEK293T cells were transfected with plasmids containing engineered AßPP harboring an amber mutation and an amber codon suppression system with an evolved tRNA synthetase/tRNA pair and grown in the presence of a lysine-derived ncAA. Processing of the AßPP variants was validated with ELISA and immunoblotting, and seven AßPP mutants that showed similar cleavage pattern as wild-type AßPP were identified. The AßPP mutant was fluorescently labeled with 6-methyl-tetrazine-BDP-FL and TMR-Star at the ncAA and SNAP-tag, respectively. Using this approach, AßPP was fluorescently labeled at two sites in living cells with minimal background to allow monitoring of Aß and C-terminal cleavage products simultaneously. The method described provides a powerful tool to label Aß with minimal perturbations of its processing, thus enabling studies of the trafficking of the cleavage products of AßPP.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Precursor de Proteína beta-Amiloide Límite: Humans Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Precursor de Proteína beta-Amiloide Límite: Humans Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Suecia